Bubs Australia gets permanent FDA authorisation for US infant formula sales
Bubs Australia said it secured permanent authorisation from the U.S. Food and Drug Administration to sell three infant formula products in the country.
S. Food and Drug Administration to sell three infant formula products in the country. The company said the move puts the stock on course for its biggest one-day gain since May 2022. 3881 Australian dollars.